Luhan Pharmachem Co., Ltd.

Home > Products > APIs > Injectable >

ANIDULAFUNGIN

Luhan pharmachem Co., Ltd. supplies Anidulafungin bulk active pharmaceutical ingredient (API) to the pharmaceutical industry. Our Anidulafungin is manufactured by cGMP compliant facility. Welcome to contact us for further details including current DMF status for the product and up to date regulatory status of the manufacturing facility. We look forward to assisting you with your research and development projects.

We supply from small R&D to commercial Quantity.

What is Anidulafungin?

Anidulafungin or Eraxis is an anti-fungal drug manufactured by Pfizer that gained approval by the Food and Drug Administration (FDA) in February 21,clinic 2006; it was previously known as LY303366. There is preliminary evidence that it has a similar safety profile to caspofungin.

Disclaimer:

Information on this page is provided for general information purposes. You should not make a clinical treatment decision based on information contained in this page without consulting other references including the package insert of the drug, sovaldi textbooks and where relevant, expert opinion. We cannot be held responsible for any errors you make in administering drugs mentioned on this page, nor for use of any erroneous information contained on this page.

About Us

Company Profile

Advantages

Strong R & D center

Qualifications

Products

APIs

Intermediates & Extracts

In development

Services

API Sourcing and Regulatory Support

Custom Synthesis

Logistics and Customs Clearance

Contact Us

Tel: +86 0871 6511 0906 (GMT+8 AM9:00-AM:12:00 PM1:30-PM6:00)

cell phone:188 1221 6310

Fax:0871-63602606

Email: info@luhancn.com

Address:Room 3301,33rd Floor Building B, Vogue Garden Plaza, No.1004 Beijing Road, Kunming, Yunnan Province, P. R. China 650000